• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过评估Rab10磷酸化来研究帕金森病相关LRRK2激酶途径的人外周血中性粒细胞分离

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation.

作者信息

Fan Ying, Tonelli Francesca, Padmanabhan Shalini, Baptista Marco A S, Riley Lindsey, Smith Danielle, Marras Connie, Howden Andrew, Alessi Dario R, Sammler Esther

机构信息

MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee.

The Michael J. Fox Foundation for Parkinson's Research.

出版信息

J Vis Exp. 2020 Mar 21(157). doi: 10.3791/58956.

DOI:10.3791/58956
PMID:32250352
Abstract

The leucine rich repeat kinase 2 (LRRK2) is the most frequently mutated gene in hereditary Parkinson' disease (PD) and all pathogenic LRRK2 mutations result in hyperactivation of its kinase function. Here, we describe an easy and robust assay to quantify LRRK2 kinase pathway activity in human peripheral blood neutrophils by measuring LRRK2-controlled phosphorylation of one of its physiological substrates, Rab10 at threonine 73. The immunoblotting analysis described requires a fully selective and phosphospecific antibody that recognizes the Rab10 Thr73 epitope phosphorylated by LRRK2, such as the MJFF-pRab10 rabbit monoclonal antibody. It uses human peripheral blood neutrophils, because peripheral blood is easily accessible and neutrophils are an abundant and homogenous constituent. Importantly, neutrophils express relatively high levels of both LRRK2 and Rab10. A potential drawback of neutrophils is their high intrinsic serine protease activity, which necessitates the use of very potent protease inhibitors such as the organophosphorus neurotoxin diisopropylfluorophosphate (DIFP) as part of the lysis buffer. Nevertheless, neutrophils are a valuable resource for research into LRRK2 kinase pathway activity in vivo and should be considered for inclusion into PD biorepository collections.

摘要

富含亮氨酸重复激酶2(LRRK2)是遗传性帕金森病(PD)中最常发生突变的基因,所有致病性LRRK2突变都会导致其激酶功能的过度激活。在此,我们描述了一种简便且可靠的检测方法,通过测量LRRK2控制的其生理底物之一Rab10在苏氨酸73处的磷酸化,来定量人外周血中性粒细胞中的LRRK2激酶途径活性。所描述的免疫印迹分析需要一种完全选择性的磷酸特异性抗体,该抗体能够识别由LRRK2磷酸化的Rab10 Thr73表位,例如MJFF-pRab10兔单克隆抗体。该方法使用人外周血中性粒细胞,因为外周血易于获取,且中性粒细胞是一种丰富且同质的成分。重要的是,中性粒细胞表达相对高水平的LRRK2和Rab10。中性粒细胞的一个潜在缺点是其较高的内在丝氨酸蛋白酶活性,这就需要使用非常有效的蛋白酶抑制剂,如有机磷神经毒素二异丙基氟磷酸酯(DIFP)作为裂解缓冲液的一部分。尽管如此,中性粒细胞仍是研究体内LRRK2激酶途径活性的宝贵资源,应考虑将其纳入PD生物样本库。

相似文献

1
Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation.通过评估Rab10磷酸化来研究帕金森病相关LRRK2激酶途径的人外周血中性粒细胞分离
J Vis Exp. 2020 Mar 21(157). doi: 10.3791/58956.
2
Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils.通过评估人中性粒细胞中 Rab10 的磷酸化来检测帕金森病 LRRK2 激酶通路活性。
Biochem J. 2018 Jan 2;475(1):23-44. doi: 10.1042/BCJ20170803.
3
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils.R1441G 突变而非 G2019S 突变增强了人外周血中性粒细胞中 LRRK2 介导的 Rab10 磷酸化。
Acta Neuropathol. 2021 Sep;142(3):475-494. doi: 10.1007/s00401-021-02325-z. Epub 2021 Jun 14.
4
Accurate MS-based Rab10 Phosphorylation Stoichiometry Determination as Readout for LRRK2 Activity in Parkinson's Disease.基于 MS 的 Rab10 磷酸化精确计量测定作为帕金森病中 LRRK2 活性的读出。
Mol Cell Proteomics. 2020 Sep;19(9):1546-1560. doi: 10.1074/mcp.RA120.002055. Epub 2020 Jun 29.
5
Development of phospho-specific Rab protein antibodies to monitor activity of the LRRK2 Parkinson's disease kinase.开发磷酸化特异性 Rab 蛋白抗体以监测 LRRK2 帕金森病激酶的活性。
Biochem J. 2018 Jan 2;475(1):1-22. doi: 10.1042/BCJ20170802.
6
The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.帕金森病 VPS35[D620N]突变增强了小鼠和人类中 LRRK2 介导的 Rab 蛋白磷酸化。
Biochem J. 2018 Jun 6;475(11):1861-1883. doi: 10.1042/BCJ20180248.
7
Cellular and subcellular localization of Rab10 and phospho-T73 Rab10 in the mouse and human brain.Rab10 和磷酸化-T73 Rab10 在小鼠和人脑内的细胞和亚细胞定位。
Acta Neuropathol Commun. 2023 Dec 18;11(1):201. doi: 10.1186/s40478-023-01704-9.
8
LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients.帕金森病患者免疫细胞中 LRRK2 介导的 Rab10 磷酸化。
Mov Disord. 2019 Mar;34(3):406-415. doi: 10.1002/mds.27601. Epub 2018 Dec 30.
9
Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites.LRRK2 磷酸化 Rab 和 Ser910/Ser935 生物标志物位点的多重靶向质谱分析方法的建立。
Biochem J. 2021 Jan 29;478(2):299-326. doi: 10.1042/BCJ20200930.
10
mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10.突变通过抑制 RAB10 在线粒体中的积累来损害去极化诱导的线粒体自噬。
Autophagy. 2020 Feb;16(2):203-222. doi: 10.1080/15548627.2019.1603548. Epub 2019 Apr 19.

引用本文的文献

1
Inflammation and IL-4 regulate Parkinson's and Crohn's disease associated kinase LRRK2.炎症和白细胞介素-4调节帕金森病和克罗恩病相关激酶LRRK2。
EMBO Rep. 2025 May 20. doi: 10.1038/s44319-025-00473-x.
2
The association between methylmalonic acid, a biomarker of mitochondrial dysfunction, and cause-specific mortality in Alzheimer's disease and Parkinson's disease.线粒体功能障碍生物标志物甲基丙二酸与阿尔茨海默病和帕金森病的特定病因死亡率之间的关联。
Heliyon. 2024 Apr 15;10(8):e29357. doi: 10.1016/j.heliyon.2024.e29357. eCollection 2024 Apr 30.
3
An Update on the Interplay between LRRK2, Rab GTPases and Parkinson's Disease.
LRRK2、Rab GTPases 与帕金森病相互作用的最新研究进展。
Biomolecules. 2023 Nov 13;13(11):1645. doi: 10.3390/biom13111645.
4
Glutamate blunts cell-killing effects of neutrophils in tumor microenvironment.谷氨酸使肿瘤微环境中的中性粒细胞的细胞杀伤作用减弱。
Cancer Sci. 2022 Jun;113(6):1955-1967. doi: 10.1111/cas.15355. Epub 2022 Apr 24.
5
LRRK2 Targeting Strategies as Potential Treatment of Parkinson's Disease.LRRK2 靶向策略作为帕金森病的潜在治疗方法。
Biomolecules. 2021 Jul 26;11(8):1101. doi: 10.3390/biom11081101.
6
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils.R1441G 突变而非 G2019S 突变增强了人外周血中性粒细胞中 LRRK2 介导的 Rab10 磷酸化。
Acta Neuropathol. 2021 Sep;142(3):475-494. doi: 10.1007/s00401-021-02325-z. Epub 2021 Jun 14.
7
Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites.LRRK2 磷酸化 Rab 和 Ser910/Ser935 生物标志物位点的多重靶向质谱分析方法的建立。
Biochem J. 2021 Jan 29;478(2):299-326. doi: 10.1042/BCJ20200930.
8
The Michael J. Fox Foundation's Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson Disease.迈克尔·J·福克斯基金会加速 LRRK2 转化为帕金森病疗法的策略。
Cells. 2020 Aug 11;9(8):1878. doi: 10.3390/cells9081878.
9
Accurate MS-based Rab10 Phosphorylation Stoichiometry Determination as Readout for LRRK2 Activity in Parkinson's Disease.基于 MS 的 Rab10 磷酸化精确计量测定作为帕金森病中 LRRK2 活性的读出。
Mol Cell Proteomics. 2020 Sep;19(9):1546-1560. doi: 10.1074/mcp.RA120.002055. Epub 2020 Jun 29.